Radioactive therapeutic agent can spare healthy tissue.
First-time software can create clear images despite metal.
Used to ID hard-to-find source of atrial fibrillation.
A new study fills in the gaps in digital breast mammography.
The actress sheds awareness on new genetic screening tool for breast cancer.
Researchers say they have found a cheaper, more effective dye.
An in-the-works implantable sensor could tell docs if a stent was failing.
New findings highlight latest trends in the global medical device market.
Are smartphones the future of patient monitors?
Bipartisan bill is introduced in the New Jersey Assembly.
Lag in health care spending may be here to stay, suggests new report.
New York Giants staffer has a big medical mission.
Researchers net grant to study new ultrasound techniques for children with Crohn's.
At IAMERS' 20th annual meeting, attendees learn how to 'thrive in chaos.'
New CMS data revealed to the public for the first time.
ASTRO and AUA guidelines recommend using radiation therapy earlier.
GHX looks for a better way to track costly implantable medical devices.
He served as events chairman for 8 years.
One of only a handful installed around the country.
Catches more than colonoscopy says study.
It may it soon be harder and costlier to bring devices to market.
Findings presented at the American Society of Breast Surgeons Annual Meeting.
FDA wants UDI surveillance to involve EHRs and apps.
Radiopharmaceutical potentially a game-changer if approved.
Growth in ambulatory health care services within the sector.
Growth of "stopgap solution" to slow down after 2014.
The IPPS rule has something to say about this type of outpatient care.
Letter from the online editor May 2013.
First-year guaranteed compensation for primary care physicians.
They might have a brighter future than you think.
Asian market will grow 5.2% over next 5 years.
Pennsylvania factory will manufacture new wireless ultrasound system.
HIT spending also slated to rise.
2013 report shows only a slight drop in the rankings.
GE will partner with Eisai on amyloid clinical trials.
Redundancy alerts can save money and dose.
